Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|---|---|
Dec. 27, 2017
USD ($)
|
Jul. 31, 2018
USD ($)
|
Jun. 30, 2019
USD ($)
customer
|
Jun. 30, 2018
USD ($)
customer
|
Jun. 30, 2019
USD ($)
customer
|
Jun. 30, 2018
USD ($)
customer
|
Sep. 30, 2018
USD ($)
customer
|
Feb. 28, 2018
USD ($)
|
|
Current accounts receivable, net | $ 4,766,962 | $ 4,766,962 | $ 3,972,632 | |||||
Net revenues | $ 9,727,060 | $ 5,501,730 | $ 23,074,984 | $ 10,661,215 | ||||
Minimum [Member] | ||||||||
Credit terms | 30 days | |||||||
Maximum [Member] | ||||||||
Credit terms | 120 days | |||||||
Assets, Current [Member] | ||||||||
Concentration risk, percentage | 15.00% | |||||||
Number of Customers | customer | 0 | 1 | ||||||
Accounts Receivable [Member] | ||||||||
Concentration risk, percentage | 76.00% | 74.00% | ||||||
Number of Customers | customer | 3 | 3 | ||||||
Total Revenue [Member] | ||||||||
Concentration risk, percentage | 63.00% | 78.00% | 64.00% | 65.00% | ||||
Number of Customers | customer | 3 | 2 | 3 | 3 | ||||
Semina [Member] | ||||||||
Current accounts receivable, net | $ 1,500,000 | |||||||
Payments to settle agreement | $ 2,200,000 | $ 1,300,000 | ||||||
Long term trade receivable | $ 7,500,000 | |||||||
Settlement loss on receivables | $ 200,000 | $ 4,000,000 | ||||||
South Africa [Member] | ||||||||
Credit terms | 150 days | |||||||
Net revenues | $ 260,644 | $ 1,791,100 | $ 494,136 | $ 2,823,970 |
X | ||||||||||
- Definition Amounts due from customers or clients, more than one year from the balance sheet date, for goods or services that have been delivered or sold in the normal course of business. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the proceeds from sale and collection of receivables during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Credit Terms No definition available.
|
X | ||||||||||
- Definition Number of Customers No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|